Current status of endoluminal grafting for exclusion of abdominal aortic aneurysms. The beauty and the beast.
The exclusion of abdominal aortic aneurysms with endoluminal grafts has generated a great deal of interest since the early 1990s, and many centers are currently evaluating the procedure and comparing it to classic surgical exclusion. Although endoluminal grafting procedures show promise, development and clinical testing of devices is a time-consuming process that is influenced greatly by the regulatory climate in the country where the clinical trials take place. Nevertheless, a number of devices are currently under study, and the advantages of 2nd- and 3rd-generation technology are reflected in reduced rates of complications such as endoleaks and thrombosis. Further study will be required to perfect these devices and observe their long-term success in the exclusion of abdominal aortic aneurysms.
Diethrich
E B
EB
Arizona Heart Institute, Phoenix 85006, USA.
D017544:Aortic Aneurysm, Abdominal / Q000401:mortality / Q000601:surgery*; D001672:Biocompatible Materials; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation* / Q000639:trends; D006801:Humans; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
D001672:Biocompatible Materials